Acta Scientific Pharmacology

Editorial Volume 2 Issue 1

The Haemocytic Haversack- Myospherulosis

Anubha Bajaj*

Department of Histopathology, Panjab University/A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Department of Histopathology, Panjab University/A.B. Diagnostics, India.

Received: November 24, 2020; Published: November 30, 2020



  Myospherulosis is an exceptional disorder with distinctive histological features comprised of a granulomatous reaction to aggregates of denatured erythrocytes interacting with endogenous and exogenous lipid-rich substances. Myospherulosis was initially scripted by McClatchie in 1969 as an uncommon, chronic inflammatory disorder demonstrating soft tissue nodules appearing as fungi-like spherules composed of red cell extravasation delineated upon sites of preceding intramuscular injections [1].



Citation: Anubha Bajaj. “The Haemocytic Haversack- Myospherulosis".Acta Scientific Pharmacology 2.1 (2021): 01-04.


Acceptance rate36%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US